
BIOPHEN⢠DTI (Direct Thrombin Inhibitors)
Price:
$436.00
Product DescriptionIn EU: This Product is CE Marked.
Health Canada Licensed. BIOPHEN DTI is a chromogenic anti-IIa assay for quantitative measurement of direct thrombin inhibitors dabigatran (PradaxaŽ) and bivalirudin (AngiomaxŽ) in human citrated plasma. Method: Patient plasma + excess human ?-thrombin (R1) ? DTI inhibits thrombin ? residual thrombin measured with chromogenic substrate (R2). For therapeutic drug monitoring, emergency quantification (ER/pre-surgery), and pharmacokinetic studies. Calibrate with Dabigatran Calibrator (222801) or Bivalirudin Calibrator (222901). Controls: Dabigatran Control (224701) + Dabigatran Control Low (225001), or DTI Control (SC030K). CE-IVD. Product Characteristics
Product Components
|
Product Applications
For the measurement of direct thrombin inhibitors in research applications.
Please Note: IVD Not for Sale in US. For US availability CLICK HERE
Material Safety Data Sheet (MSDS)Certificate of Analysis (COA) |